The first experience in the treatment of large penetrating wounds of the sclera using expanded primary microsurgical treatment

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND: According to the literature, the absence of pattern vision in the outcome of open wounds of the eyeball is observed in 25–30% of cases, and in the presence of large wounds with multiple injuries of intraocular structures, it is 61–80%.

AIM: to present the results of expanded microsurgical treatment of large penetrating corneoscleral and scleral wounds involving the zone III, to evaluate the results of the given algorithm for severe penetrating injury care.

MATERIALS AND METHODS: Presented are the results of treatment of 24 patients with large penetrating corneoscleral and scleral wounds, massive hemophthalmos, and other injuries. All patients underwent primary microsurgical treatment according to a modified, expanded algorithm, which, in addition to suturing the fibrous capsule of the eye, included subtotal vitrectomy, primary treatment of retinal and choroidal wounds, the use of autologous conditioned plasma (P-PRP) , tamponade with silicone oil or a gas-air mixture.

RESULTS: Evaluation of treatment results was carried out on day 3, after 1 and 6 months. Special attention was paid to the identification of signs of proliferative vitreoretinopathy as most important in terms of prognosis. After 6 months, visual acuity above 0.1 was noted in 10 patients, 0.02–0.09 in 12, absence of pattern vision in 2. Signs of development and progression of PVR during 6 months were noted in 7 patients (29.2%), of which repeated surgeries were performed in 5 cases.

CONCLUSIONS: The new advanced algorithm of primary microsurgical treatment allows to improve functional results in severe cases of penetrating eye injury.

About the authors

Sergey S. Shamkin

Central City Clinical Hospital No. 23

Author for correspondence.
Email: SergeyShamkin87@yandex.ru
ORCID iD: 0000-0002-3504-8886

Head of the Service Department, Ophthalmologist

Russian Federation, Ekaterinburg

Serafima N. Subbotina

Central City Clinical Hospital No. 23

Email: shmaksn@yandex.ru
ORCID iD: 0000-0001-9284-6502

Doctor of the Ophthalmological Department

Russian Federation, Ekaterinburg

Armen B. Stepanyants

Ural State Medical University

Email: stepanyants@okb1.ru

MD, Dr. Sci. (Med.), Professor, Head of Advanced Medical Education Course, Head of Ophthalmology Department

Russian Federation, Ekaterinburg

References

  1. Kolesnikov AV, Kirsanova IV, Averina MM, Grishina TD. Results of treatment of penetrating wounds of the eyeball. Sovremennye Tekhnologii v Oftal’mologii. 2021;3:330–332. (In Russ.) doi: 10.25276/2312-4911-2021-3-330-332
  2. Gundorova RA. Priority trends in the sphere of eye traumatism. The Russian Annals of Ophthalmology. 2004;110(1):12–14. (In Russ.)
  3. Gundorova RA, Stepanov AV, Kurbanova NF. Sovremennaya oftal’motravmatologiya. Moscow: Meditsina. 2007. 256 p. (In Russ.)
  4. Knyazer B, Levy J, Rosen S, et al. Prognostic factors in posterior open globe injuries (zone-III injuries). Clin Exp Ophthalmol. 2008;36(9):836–841. doi: 10.1111/j.1442-9071.2009.01922.x
  5. Blackford BG, Justin GA, Baker KM, et al. Proliferative vitreoretinopathy after combat ocular trauma in Operation Iraqi Freedom and Operation Enduring Freedom: 2001–2011. Ophthalmic Surg. Lasers Imaging Retina. 2020;51(10):556–563. doi: 10.3928/23258160-20201005-03
  6. Soni NG, Bauza AM, Son JH, et al. Open globe ocular trauma: functional outcome of eyes with no light perception at initial presentation. Retina. 2013;33(2):380–386. doi: 10.1097/IAE.0b013e318263cefb
  7. Jin Y, Chen H, Xu X, et al. Traumatic proliferative vitreoretinopathy. Clinical and histopathological observations. Retina. 2017;37(7):1236–1245. doi: 10.1097/IAE.0000000000001350
  8. Morescalchi F., Duse S., Gambicorti E., et al. Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading toa retinal keloid. Mediators Inflamm. 2013:269787. doi: 10.1155/2013/269787
  9. Andreoli M, Andreoli C. Surgical rehabilitation of the open globe injury patient. Am J Ophthalmol. 2012;153(5):856–860. doi: 10.1016/j.ajo.2011.10.013
  10. Stepanyants AB. Metody ballonirovaniya v khirurgii povrezhdenii sklery. Oftal’mokhirurgiya. 2008;(2):50–55. (In Russ.)
  11. Pieramici DJ, MacCumber MW, Humayun MU. Open-globe injury. Update on types of injuries and visual results. Ophthalmology. 1996;103(11):1798–1803. doi: 10.1016/s0161-6420(96)30424-7
  12. Kasymov FO, Kulikov VS, Nikolaenko VP, Zumbulidze NG. Mekhanicheskaya travma organa zreniya. Saint Petersburg: SZGMU im. I.I. Mechnikova. 2015. 51 p. (In Russ.)
  13. Neroev VV, Chentsova EV, Alekseeva IB, Kulikov AN. Klinicheskie rekomendatsii. Otkrytaya travma glaza: klinika, diagnostika, lechenie. Moscow: Obshcherossiiskaya obshchestvennaya organizatsiya “Assotsiatsiya vrachei-oftal’mologov”; 2017. 32 p. (In Russ.)
  14. Stepanyants AB. Sistema kompleksnoi diagnostiki, khirurgicheskogo lecheniya i reabilitatsii patsientov s povrezhdeniyami sklery [dissertation]. Moscow; 2009. 223 p. (In Russ.)
  15. Kuhn F, Schrader W. Prophylactic chorioretinectomy for eye injuries with high proliferative-vitreoretinopathy risk. Clin Anat. 2018;31(1):28–38. doi: 10.1002/ca.22906
  16. Shishkin MM. Perednyaya proliferativnaya vitreoretinopatiya (patogenez, lechenie, profilaktika) [dissertation abstract]. Saint Petersburg; 2000. 51 p. (In Russ.)
  17. Volkov VV. Pozitivnyi opyt organizatsii oftal’mokhirurgicheskoi pomoshchi pri otkrytoi travme glaza (OTG) v usloviyakh massovykh porazhenii. In: VIII All-Russian Scientific and Practical Conference with international participation “Fedorovskie chteniya – 2009”: Sbornik tezisov po materialam konferentsii (2009, 1–3 July). Moscow; 2009. Available from: https://eyepress.ru/repository/record.aspx?oai: eyepress.ru: article6556
  18. Kuhn F, Morris R. Early vitrectomy for severe eye injuries. Eye (Lond). 2021;35(5):1288–1289. doi: 10.1038/s41433-020-01308-w
  19. Ishikawa K, He S, Terasaki H, et al. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Sci Rep. 2015;5:16386. doi: 10.1038/srep16386
  20. Tamiya Sh, Liu L, Kaplan H. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci. 2010;51(5):2755–2763. doi: 10.1167/iovs.09-4725
  21. Popov EM, Kulikov AN, Churashov SV, et al. Comparison of indicators of autologous serum obtained by different methods and used for the treatment of macular hole. Ophthalmology Journal. 2021;14(4):27–34. (In Russ.) doi: 10.17816/OV89413
  22. Pashtaev NP, Arsyutov DG. The use of medical glue in the treatment of progressive myopia and retinal detachment. Oftal’mokhirurgiya. 2009;(3):16–20. (In Russ.)
  23. Shkvorchenko DO, Zakharov VD, Shpak AA. Nash pervyi opyt primeneniya bogatoi trombotsitami plazmy krovi v khirurgii makulyarnykh razryvov. Sovremennye Tekhnologii v Oftal’mologii. 2016;(1):245–246. (In Russ.)
  24. Arsiutov DG. The use of a new type of platelet-rich plasma — autologous conditioned plasma (ACP) in the surgery of rhegmatogenous retinal detachment with large and multiple breaks, abruption from the dentate line. Sovremennye Tekhnologii v Oftalmologii. 2019;1:22–25. (In Russ.) doi: 10.25276/2312-4911-2019-1-22-25
  25. Arsiutov DG. Use of Autologous Conditioned Platelet Rich Plasma in the Surgery of Rhegmatogenous Retinal Detachment with Central and Peripheral Tears. Acta Biomedica Scientifica. 2019;4(4):61–65. (In Russ.) doi: 10.29413/ABS.2019-4.4.8
  26. Arsyutov DG. Use of platelet rich plasma, including autologous conditioned plasma, in the surgery of perforating eye injuries. Saratov Journal of Medical Scientific Research. 2020;16(1): 207–210. (In Russ.)

Copyright (c) 2023 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies